Haemonetics (HAE) Acquisitions (2020 - 2024)
Haemonetics has reported Acquisitions over the past 9 years, most recently at $1.8 million for Q3 2024.
- For Q3 2024, Acquisitions changed N/A year-over-year to $1.8 million; the TTM value through Jun 2025 reached $1.8 million, down 99.55%, while the annual FY2025 figure was $150.9 million, 38.12% down from the prior year.
- Acquisitions for Q3 2024 was $1.8 million at Haemonetics, down from $149.2 million in the prior quarter.
- Over five years, Acquisitions peaked at $418.2 million in Q2 2021 and troughed at $1.8 million in Q3 2024.
- A 5-year average of $119.3 million and a median of $16.6 million in 2020 define the central range for Acquisitions.
- Biggest five-year swings in Acquisitions: tumbled 84.95% in 2021 and later increased 14.0% in 2022.
- Year by year, Acquisitions stood at $16.6 million in 2020, then tumbled by 84.95% to $2.5 million in 2021, then rose by 14.0% to $2.8 million in 2022, then surged by 8456.21% to $243.9 million in 2023, then plummeted by 99.28% to $1.8 million in 2024.
- Business Quant data shows Acquisitions for HAE at $1.8 million in Q3 2024, $149.2 million in Q2 2024, and $243.9 million in Q4 2023.